Loading market dashboard
ImmuPharma plc
IMM.LHealthcareLSEGB
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
ImmuPharma plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $100.0K | $100.0K - $100.0K | $60.0K | -$0.029 | 1 |
| Dec 2029 | $100.0K | $100.0K - $100.0K | $60.0K | -$0.028 | 1 |
| Dec 2028 | $100.0K | $100.0K - $100.0K | $60.0K | -$0.029 | 1 |
| Dec 2027 | $100.0K | $100.0K - $100.0K | $60.0K | -$0.043 | 1 |
| Dec 2026 | $100.0K | $100.0K - $100.0K | $60.0K | -$0.032 | 1 |
| Dec 2025 | $100.0K | $100.0K - $100.0K | $60.0K | -$0.032 | 1 |
| Dec 2024 | $100.0K | $100.0K - $100.0K | $60.0K | -$0.029 | 1 |
| Dec 2021 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.029 | 1 |
| Dec 2020 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.028 | 1 |
| Dec 2019 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.029 | 1 |
| Dec 2018 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.043 | 1 |
| Dec 2017 | $100.0K | $100.0K - $100.0K | $20.0K | -$0.032 | 1 |